FDA Approves Lurbinectedin for Metastatic Small Cell Lung Cancer

The FDA has approved lurbinectedin (Zepzelca) for the treatment of adult patients with metastatic small cell lung cancer with disease progression, following platinum-based chemotherapy.

Read the full article here

Related Articles